Impact of Early Antimalarial Adherence on Future Acute Care Utilization and Cost Among Patients With Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Population‐Based Study
Arthritis & Rheumatology · 2026-07 · 78 (7) · 1414-1424
DOI: 10.1002/art.70071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 17.02.2026. Verfasst von Md Rashedul Hoque und 7 weiteren Autor:innen. Beteiligte Einrichtung: Arthritis Research Canada, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Antimalarials, Lupus Erythematosus, Systemic, Hospitalization. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: CIHR, Natural Sciences and Engineering Research Council of Canada, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Objective
To assess the association between early antimalarial adherence and future acute care utilization and cost in a population‐based cohort of incident rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE).
Methods
All patients with incident RA/SLE and new antimalarial use in British Columbia, Canada, between January 1997 and March 2022 with at least one year of follow‐up were identified using provincial administrative databases. Each antimalarial adherent patient (proportion of days covered [PDC] ≥ 0.90) was propensity score (PS) matched up to two antimalarial nonadherent patients (0 < PDC < 0.90). The outcomes hospital admissions, hospitalized days, and hospitalization cost were assessed in the following year. We estimated the impact of early antimalarial adherence on these outcomes, accounting for potential confounders, using quasi‐Poisson and linear models with robust SEs. We conducted falsification tests and sensitivity analyses to examine robustness to healthy adherer effect and unmeasured confounders.
Results
We identified 8,768 antimalarial adherent and 16,479 antimalarial nonadherent PS‐matched individuals with RA/SLE. The adjusted rate ratios of hospital admissions and hospitalized days obtained for antimalarial adherent versus nonadherent patients were 0.89 (95% confidence interval [CI] 0.84–0.94) and 0.79 (95% CI 0.71–0.88), respectively. The adjusted average hospitalization costs were lower (estimate: CAD −$549.64, 95% CI −$896.05 to −$203.22, P < 0.01) for antimalarial adherent patients than nonadherent patients. Falsification tests and sensitivity analyses confirmed the robustness of the results.
Conclusion
Adherence to antimalarials in patients with RA and SLE was associated with a lower risk of hospital admission (11% reduction) and hospitalized days (21% reduction) and lower hospitalization costs (CAD $549.64 lower) compared to nonadherence. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Arthritis Research Canada, Vancouver, British Columbia, Canada.
- Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada.
- Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
- Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
- Sauder School of Business, University of British Columbia, Vancouver, British Columbia, Canada.
ORCID-Profile: Md Rashedul Hoque, Diane Lacaille, J Antonio Aviña-Zubieta, Mary A De Vera, Hui Xie
Förderung
- CIHR
- Natural Sciences and Engineering Research Council of Canada
- Canadian Institutes of Health Research
Zitieren
APA
Hoque, M. R., Lacaille, D., Aviña-Zubieta, J. A., De Vera, M. A., Qian, Y., McCandless, L., Esdaile, J. M., & Xie, H. (2026). Impact of Early Antimalarial Adherence on Future Acute Care Utilization and Cost Among Patients With Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Population‐Based Study. Arthritis & Rheumatology, 78(7), 1414-1424. https://doi.org/10.1002/art.70071
Vancouver
Hoque MR, Lacaille D, Aviña-Zubieta JA, De Vera MA, Qian Y, McCandless L, et al. Impact of Early Antimalarial Adherence on Future Acute Care Utilization and Cost Among Patients With Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Population‐Based Study. Arthritis & Rheumatology. 2026;78(7):1414-1424. doi:10.1002/art.70071
BibTeX
@article{Hoque2026,
author = {Hoque, Md Rashedul and Lacaille, Diane and Aviña-Zubieta, J Antonio and De Vera, Mary A and Qian, Yi and McCandless, Lawrence and Esdaile, John M and Xie, Hui},
title = {Impact of Early Antimalarial Adherence on Future Acute Care Utilization and Cost Among Patients With Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Population‐Based Study},
journal = {Arthritis & Rheumatology},
year = {2026},
volume = {78},
number = {7},
pages = {1414--1424},
doi = {10.1002/art.70071}
}
EUVIMED